To cite this paper use one of the standards below:
Lung cancer is a highly prevalent and lethal neoplasm. Its high mortality rate is primarily due to its diagnosis at advanced stages, which significantly reduces patient survival time. Nanomedicine therapeutic alternatives aimed at minimizing the side effects and enhancing treatment efficacy. This study explores nanoemulsion and nanoprecipitation synthesis methods to develop a nanosystem using the biocompatible copolymer poly(lactic-co-glycolic acid) (PLGA) for paclitaxel delivery. Our findings reveal that nanoparticles produced via the nanoemulsion technique had an average diameter of 210 ± 2 nm, a polydispersity index (PDI) of 0.14 ± 0.02, a zeta potential of -8.7 ± 0.8 mV, and an encapsulation efficiency of 58%. In contrast, nanoparticles synthesized using the nanoprecipitation technique exhibited sizes of ca. 370 ± 90 nm, a PDI of 0.67 ± 0.04, and a zeta potential of -20 ± 8 mV. The latter formulation presented aggregation over time, which negatively affects their stability and circulation time in vivo. Additionally, these nanoparticles will be subjected to scanning electron microscopy, cytotoxicity assays, and cell internalization studies to assess their morphology, safety profile, and in vitro toxicity. Our findings may represent a promising and safe alternative for lung cancer therapy.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper